Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression

Journal of Neuro-Oncology

Volumn 64, Issue 1, 2003, Pages 45-54

  Prins, Robert M ^b,c   Graf, Martin R ^b   Merchant, Randall E ^b   Black, Keith L ^a   Wheeler, Christopher J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Glioma; Glucocorticoids; Recent thymic emigrants; T lymphocytes; Thymus; Tumor immunity

Indexed keywords

GLUCOCORTICOID; LIPOCORTIN 5;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BRAIN CORTEX; CANCER GROWTH; CANCER IMMUNOLOGY; CELL LOSS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; HUMAN CELL; INVOLUTION; LYMPHOCYTE MIGRATION; LYMPHOCYTOPOIESIS; MEDULLA OBLONGATA; MICROSCOPY; NONHUMAN; RAT; THYMOCYTE; THYMUS FUNCTION;

EID: 0042063646     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024929724736     Document Type: Conference Paper

References (35)

1. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR: Brain tumor survival: Results from the National Cancer Data Base. J Neuro-Oncol 40: 151-160, 1998
2. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC: Regulation of cutaneous malignancy by gammadelta T cells. Science 294: 605-609, 2001
3. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenecity. Nature 410: 1107-1111, 2001
4. Walker PR, Calzascia T, Schnuriger V, Scamuffa N, Saas P, De Tribolet N, Dietrich PY: The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells. J Immunol 165: 3128-3135, 2000
5. Sogn JA: Tumor immunology: The glass is half full. Immunity 9: 757-763, 1998
6. Brooks WH, Roszmann TL, Rogers AS: Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors. Cancer 37: 1869-1873, 1976
7. Brooks WH, Roszman TL, Mahaley MS, Woosley RE: Immunobiology of primary intracranial tumours. II Analysis of lymphocyte subpopulations in patients with primary brain tumours. Clin Exp Immunol 29: 61-66, 1977
8. Mahaley MS Jr, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S: Immunobiology of primary intracranial tumours. Part 1: Studies of the cellular and humoral, general immune competence of brain-tumor patients. J Neurosurg 46: 467-476, 1977
9. Dix AR, Brooks WH, Roszman TL, Morford LA: Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100: 216-232, 1999
10. Jamieson BD, Douek DC, Killian S, Hultin LE, Scripture-Adams DD, Giorgi JV, Marelli D, Koup RA, Zack JA: Generation of functional thymocytes in the human adult. Immunity 10: 569-575, 1999
11. Ellmeier W, Sawada S, Littman DR: The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu Rev Immunol 17: 523-554, 1999
12. Blom B, Res PC, Spits H: T cell precursors in man and mice. Crit Rev Immunol 18: 371-388, 1998
13. Barth RF: Rat brain tumor models in experimental neurooncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neuro-Oncol 36: 91-102, 1998
14. Graf MR, Merchant RE: Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats. J Neuro-Oncol 45: 209-218, 1999
15. Kamath AB, Xu H, Nagarkatti PS, Nagarkatti M: Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol Appl Pharmacol 142: 367-377, 1997
16. Tarcic N, Ovadia H, Weiss DW, Weidenfeld J: Restraint stress-induced thymic involution and cell apoptosis are dependent on endogeous glucocorticoids. J Neuroimmunol 82: 40-46, 1998
17. Hosseinzadeh H, Goldschneider I: Recent thymic emigrants in the rat express a unique antigenic phenotype and undergo post-thymic maturation in peripheral lymphoid tissue. J Immunol 150: 1670-1679, 1993
18. Douek DC, McFarland, RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA: Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695, 1998
19. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP: The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 18: 529-560, 2000
20. Hochberg EP, Chillemi AC, Wu CJ, Neuberg D, Canning C, Hartman K, Alyea EP, Soiffer RJ, Kalams SA, Ritz J: Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 98: 1116-1121, 2001
21. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B, Roosnek E: Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96: 2299-2303, 2000
22. Zhou T, Edwards CK III, Mountz JD: Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 182: 129-137, 1995
23. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E: Loss of T-cell receptor zeta chain and p561ck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53: 5613-5616, 1993
24. Prins RM, Graf MR, Merchant RE: Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis. Cancer Immunol Immunother 50: 285-292, 2001
25. Reichert TE, Day R, Wagner EM, Whiteside TL: Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res 58: 5344-5347, 1998
26. Grody WW, Fligiel S, Naeim F: Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol 84: 85-95, 1985
27. Wykrzykowska JJ, Rosenzweig M, Veazey RS, Simon MA, Halvorsen K, Desrosiers RC, Johnson RP, Lackner AA: Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med 187: 1767-1778, 1998
28. Adkins B, Charyulu V, Sun QL, Lobo D, Lopez DM: Early block in maturation is associated with thymic involution in mammary tumor-bearing mice. J Immunol 164: 5635-5640, 2000
29. Fu Y, Paul RD, Wang Y, Lopez DM: Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. J Immunol 143: 4300-4307, 1989
30. Zeytun A, Nagarkatti M, Nagarkatti PS: Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas(+) organs. Blood 95: 2111-2117, 2000
31. Gruber J, Sgonc R, Hu YH, Beug H, Wick G: Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur J Immunol 24: 1115-1121, 1994
32. McVicar DW, Davis DF, Merchant RE: In vitro analysis of the proliferative potential of T cells from patients with brain tumor: Glioma-associated immunosuppression unrelated to intrinsic cellular defect. J Neurosurg 76: 251-260, 1992
33. Todo T, Rabkin SD, Chahlavi A, Martuza RL: Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy. Hum Gene Ther 10: 2869-2878, 1999
34. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL: T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 159: 4415-4425, 1997
35. Morford LA, Dix AR, Brooks WH, Roszman TL: Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors. J Neurosurg 91: 935-946, 1999